Objectives Elevations of cardiac troponin T (cTnT) levels are common after strenuous exercise. We assessed whether the ...

The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

Roche Holding AG (RHHVF) Company Description: Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SkyQuest projects that the global pyrogen testing market size will reach a value of USD 4.10 Billion by 2031 , with a CAGR of 13.4% during the forecast period (2024-2031). Growing demand for pyrogen ...

Roche is reported to be considering the sale of its cancer data specialist Flatiron Health, just a few years after it bought the company for $1.9 billion. The Financial Times first revealed the ...

Roche noted in its update that giredestrant is also in additional studies as a first-line therapy for advanced breast cancer and for early-stage breast cancer. Diagnostics drive Q1 performance The ...